Solubilization and Iterative Saturation Mutagenesis of α1,3‐fucosyltransferase from Helicobacter pylori to enhance its catalytic efficiency

α1,3‐Fucosyltransferase (α1,3‐FucT) is essential for the biosynthesis of biologically active α1,3‐fucosyloligosacchairdes (3‐FOs) from human milk oligosaccharides (HMO), particularly 3‐fucosyllactose (3‐FL) trisaccharide. α1,3‐FucT from Helicobacter pylori 26695 (FutA) accepts lactose and LacNAc as glycan acceptors and has a very low level of expression in Escherichia coli, and it shows a low catalytic activity for lactose in the large‐scale synthesis of 3‐FL. To overcome the poor solubility of FutA, codon optimization, and systematic truncation of the protein at the C‐terminus with only one heptad repeat remaining (Δ52 FutA) were conducted to yield 150–200 mg/L of soluble protein of FutA and resulting in more than an 18‐fold increase in the 3‐FL yield. To improve the low level of enzyme catalytic activity for lactose, focused directed evolution was attempted using a semi‐rational approach that combines structure‐guided computational analysis and subsequent iterative saturation mutagenesis (ISM). In order to select the functional residues in active site/substrate binding site, docking simulation was used together with HotSpot Wizard to target evolutionarily variable amino acid positions. A128 site was selected from the key residue located in the active site, and A128N mutant displayed a 3.4‐fold higher catalytic activity than wild‐type Δ52 FutA. Considering that the A128N mutation is located in the deep cleft of the lactose binding site, the residues within the substrate binding sites, especially on the two α‐helices for lactose and one α‐helix for GDP‐fucose, were subjected to structure‐guided ISM. The selected residues from each helix were clustered, and ISM was performed for each cluster in parallel. In particular, the mutant with triple mutations (A128N/H129E/Y132I) located on the α5 helix exhibited a 9.6‐fold improvement in specific activity when compared to wild‐type Δ52 FutA. When such clustered mutations on two α‐helices (α5 and α2/loop) were combined, mutants with triple (A128N/H129E/S46F) and quadruple mutations (A128N/H129E/Y132I/S46F) were generated, which showed the synergistic effects, that is 14.5‐ and 15.5‐fold improvement in specific activity relative to wild‐type Δ52 FutA, respectively. The mutations increased their binding affinity for lactose and kcat values for lactose and GDP‐fucose. The Δ52 FutA quadruple mutant (A128N/H129E/Y132I/S46F) was successfully applied to in vitro synthesis of 3‐FL with an improved yield and productivity (>96% yield based on 5 mM of GDP‐Fuc within 1 h). Biotechnol. Bioeng. 2016;113: 1666–1675. © 2016 Wiley Periodicals, Inc.

[1]  G. Sprenger,et al.  Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2′-fucosyllactose , 2013, Microbial Cell Factories.

[2]  Chun-Hung Lin,et al.  Carboxyl terminus of Helicobacter pylori alpha1,3-fucosyltransferase determines the structure and stability. , 2006, Biochemistry.

[3]  Gavin J. Williams,et al.  Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution. , 2007, Nature chemical biology.

[4]  Amir Aharoni,et al.  High-throughput screening methodology for the directed evolution of glycosyltransferases , 2006, Nature Methods.

[5]  J. Sohng,et al.  Expanding substrate specificity of GT‐B fold glycosyltransferase via domain swapping and high‐throughput screening , 2009, Biotechnology and bioengineering.

[6]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[7]  D. Newburg,et al.  Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. , 2013, Glycobiology.

[8]  M. Palcic,et al.  Purification, Kinetic Characterization, and Mapping of the Minimal Catalytic Domain and the Key Polar Groups of Helicobacter pylori α-(1,3/1,4)-Fucosyltransferases* , 2006, Journal of Biological Chemistry.

[9]  B. Ramakrishnan,et al.  Substrate-induced conformational changes in glycosyltransferases. , 2005, Trends in biochemical sciences.

[10]  Michael J. Miller,et al.  Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli , 2012, Microbial Cell Factories.

[11]  M. Altaye,et al.  Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. , 2001, Glycobiology.

[12]  S. Withers,et al.  Fluorescence activated cell sorting as a general ultra-high-throughput screening method for directed evolution of glycosyltransferases. , 2010, Journal of the American Chemical Society.

[13]  D. Newburg,et al.  Recent advances in human milk glycobiology , 2014, Pediatric Research.

[14]  Alan Villalobos,et al.  Design Parameters to Control Synthetic Gene Expression in Escherichia coli , 2009, PloS one.

[15]  Marc Ostermeier,et al.  Mathematical expressions useful in the construction, description and evaluation of protein libraries. , 2005, Biomolecular engineering.

[16]  Uwe T Bornscheuer,et al.  Strategies for the discovery and engineering of enzymes for biocatalysis. , 2013, Current opinion in chemical biology.

[17]  J. Sohng,et al.  Cloning and functional characterization of an α-1,3-fucosyltransferase from Bacteroides fragilis , 2013, Biotechnology and Bioprocess Engineering.

[18]  C. Lebrilla,et al.  Human milk glycobiome and its impact on the infant gastrointestinal microbiota , 2010, Proceedings of the National Academy of Sciences.

[19]  A. Bechthold,et al.  Engineering a function into a glycosyltransferase. , 2009, Chemistry & biology.

[20]  H. Schroten,et al.  Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines. , 2013, Nutrition research.

[21]  Manfred T Reetz,et al.  Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes , 2007, Nature Protocols.

[22]  E. Samain,et al.  Large-scale synthesis of H-antigen oligosaccharides by expressing Helicobacter pylori alpha1,2-fucosyltransferase in metabolically engineered Escherichia coli cells. , 2006, Angewandte Chemie.

[23]  M. Kitaoka,et al.  Physiology of Consumption of Human Milk Oligosaccharides by Infant Gut-associated Bifidobacteria* , 2011, The Journal of Biological Chemistry.

[24]  A. H. Wang,et al.  Structure and Mechanism of Helicobacter pylori Fucosyltransferase , 2007, Journal of Biological Chemistry.

[25]  Byung-Gee Kim,et al.  Protein engineering of α2,3/2,6-sialyltransferase to improve the yield and productivity of in vitro sialyllactose synthesis. , 2014, Glycobiology.

[26]  Lars Bode,et al.  Human milk oligosaccharides: every baby needs a sugar mama. , 2012, Glycobiology.

[27]  Sophie Drouillard,et al.  Large‐Scale Synthesis of H‐Antigen Oligosaccharides by Expressing Helicobacter pylori α1,2‐Fucosyltransferase in Metabolically Engineered Escherichia coli Cells , 2006 .

[28]  Antonín Pavelka,et al.  HotSpot Wizard: a web server for identification of hot spots in protein engineering , 2009, Nucleic Acids Res..

[29]  M. Heidtman,et al.  The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. , 2013, Glycobiology.

[30]  Xi Chen,et al.  Cytidine 5'-monophosphate (CMP)-induced structural changes in a multifunctional sialyltransferase from Pasteurella multocida. , 2006, Biochemistry.

[31]  Dan S. Tawfik,et al.  Directed enzyme evolution: beyond the low-hanging fruit. , 2012, Current opinion in structural biology.

[32]  C. Dumon,et al.  Assessment of the Two Helicobacter pylori α‐1,3‐Fucosyltransferase Ortholog Genes for the Large‐Scale Synthesis of LewisX Human Milk Oligosaccharides by Metabolically Engineered Escherichia coli , 2008, Biotechnology progress.

[33]  G. Coppa,et al.  Human Milk Oligosaccharides Inhibit the Adhesion to Caco-2 Cells of Diarrheal Pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris , 2006, Pediatric Research.

[34]  P. Alzari,et al.  Structure-function relationships of membrane-associated GT-B glycosyltransferases. , 2014, Glycobiology.

[35]  G J Davies,et al.  Glycosyltransferases: structures, functions, and mechanisms. , 2008, Annual review of biochemistry.

[36]  H. Kumagai,et al.  Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. , 2009, Glycobiology.

[37]  Stefan Lutz,et al.  Beyond directed evolution--semi-rational protein engineering and design. , 2010, Current opinion in biotechnology.